...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: "Groundbreaking".......

Good choice of language....very positive sounding, and very accurate imo.  Before building any structure you first have to "break ground".  I don't recall a NR from the company being this bullish sounding:  "remarkable results"...."shocking and highly encouraging"....

Hopefully this is just the beginning of the company touting the potential for Apabetalone.....interesting though that we have a phase III trial going on and its a Ph I trial that seems to be driving the interest....but no matter.  When my team wins I don't care if they won because of offense, defense, special teams or luck....so long as they win.

New Message
Please login to post a reply